Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)

CNY 3.21

(-0.93%)

Market Cap (In CNY)

6.62 Billion

Revenue (In CNY)

1.76 Billion

Net Income (In CNY)

-195.32 Million

Avg. Volume

29.55 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.03-3.88
PE
-
EPS
-
Beta Value
0.31
ISIN
CNE100001781
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Qingrong Sun
Employee Count
-
Website
https://www.hnerkang.com
Ipo Date
2011-09-27
Details
Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. The company was founded in 2003 and is based in Liuyang, China.